Critical points in secondary myocardial infarction trials.
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D010976:Platelet Count; D011379:Prognosis; D012008:Recurrence
D000925:Anticoagulants